ChromaDex Corp (NAS:CDXC)
$ 7.72 0.08 (1.05%) Market Cap: 589.68 Mil Enterprise Value: 560.33 Mil PE Ratio: 772.00 PB Ratio: 17.08 GF Score: 75/100

Chromadex Corp at LD Micro Invitational Conference Transcript

Jun 06, 2023 / 08:30PM GMT
Release Date Price: $1.57 (+0.32%)
Unidentified Participant

Good afternoon, everyone. I hope everyone had a lovely lunch. We're excited to welcome our next presentation from ChromaDex. We have Brianna Gerber and Rob Fried.

Rob Fried
ChromaDex Corp. - CEO

Thank you very much. Thank you, everybody. It's exciting to be here again. Nice to see you all here. A couple of familiar faces.

Show of hands, quickly, how many people here have heard of NAD, nicotinamide adenine dinucleotide? One, two three, four, five, six seven, about half of you -- a little less than half. Nicotinamide adenine dinucleotide is a co-enzyme found in all living cells, plant, and animal. It's involved in every important metabolic process inside the cell, but most notably energy metabolism and cell repair.

There are organelles inside of cells called mitochondria, which are responsible for taking nutrients from food and oxygen from air, and converting it into actual energy, which is then transferred throughout the cell through molecules called adenosine triphosphate, ATP molecules, all of which everybody here in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot